NCT07554404

Brief Summary

This study aims to validate the Ventriject Seismofit device by comparing VO2 Max obtained via the Seismofit and traditional Cardiopulmonary Exercise Testing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 9, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 28, 2026

Completed
Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 21, 2026

Last Update Submit

April 21, 2026

Conditions

Keywords

VO2 Max

Outcome Measures

Primary Outcomes (1)

  • VO2 Max

    Maximal oxygen uptake obtained via Cardiopulmonary Exercise Test on a cycle, as well as the Seismofit at rest.

    Cross-sectional data collected at one time. Total data collection will occur over 3 months.

Secondary Outcomes (1)

  • Body Fat %

    Cross-sectional data collected at one time. Total data collection will occur over 3 months.

Interventions

VO2 MaxOTHER

Comparing maximal oxygen uptake obtained from Cardiopulmonary Exercise Test and Seismofit

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy adults in Maryland

You may qualify if:

  • Healthy adults 18-65 years old
  • Provide health history questionnaire and informed consent

You may not qualify if:

  • Known chronic disease (cardiovascular, pulmonary, and/or metabolic disease)
  • Orthopedic Concern
  • Acute illness during day of test
  • Severe Hypertension (SBP \>200 and/or DBP \> 110) at rest
  • Reported pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Salisbury University

Salisbury, Maryland, 21801, United States

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 21, 2026

First Posted

April 28, 2026

Study Start

October 9, 2025

Primary Completion

December 1, 2025

Study Completion

December 5, 2025

Last Updated

April 28, 2026

Record last verified: 2026-04

Locations